19 Oct 2022 --- DSM is gearing up to present its latest pharmaceutical, consumer health and medical nutrition solutions at CPHI 2022 in Frankfurt, Germany (Nov 1-3). Visitors to booth 120B120 will discover pioneering technologies to enhance cannabidiol (CBD) bioavailability and new drug delivery formats. Scientific evidence increasingly points to the potential of CBD as a key ingredient across multiple health areas, including central nervous system (CNS) diseases, pain management, cancer and mood disorders.
